Cell cycle analysis of the primary human GBM cells with low and moderate expression of total Pyk2, and GL261 mouse cells, revealed an increase in the G2/M and sub-G1 populations following 72 h TMZ treatment, along with upregulation of Bcl2 expression, indicating cell cycle arrest. The gene discussed is PTK2B; the disease is glioblastoma.